Literature DB >> 17336356

Identification of a proteinase K resistant protein for use as an internal positive control marker in PrP Western blotting.

G C Saunders1, V Horigan, A C Tout, O Windl.   

Abstract

The routine use of an internal positive control (IPC) marker could prove useful in the diagnosis of transmissible spongiform encephalopathy (TSE) diseases, particularly in surveillance programmes where large numbers of negative results are reported. Detection of an endogenous IPC protein in a negative sample adds confidence to the correct sample processing throughout the analytical procedure and could avoid the reporting of false negative diagnoses. Proteinase K (PK) resistance is one of the key diagnostic determinants of the disease-associated form of PrP (PrP(Sc)), the only disease-specific macromolecule currently associated with TSE disease. Additional PK resistant proteins, endogenous to TSE-suspect diagnostic tissue samples, were therefore assessed for use as IPC markers in the Western blot diagnosis of BSE and scrapie. Results indicated that, whilst essentially maintaining a standard PrP extraction and detection protocol, a ferritin heavy chain sub-unit of approximately 22kDa, was consistently detected in all PK treated TSE positive and negative tissue samples tested. Its presence in a range of sample types, any of which could be submitted under BSE and scrapie surveillance programmes, confirmed it as a suitable protein for an IPC marker in PrP(Sc) Western blotting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336356     DOI: 10.1016/j.rvsc.2007.01.001

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  5 in total

1.  Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Authors:  Ajay Singh; Liuting Qing; Qingzhong Kong; Neena Singh
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

2.  Endoplasmic reticulum stress is transmissible in vitro between cells of the central nervous system.

Authors:  Neil T Sprenkle; Anirudhya Lahiri; James W Simpkins; Gordon P Meares
Journal:  J Neurochem       Date:  2019-01-18       Impact factor: 5.372

Review 3.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Matthew K McElwee; Katharine Horback; Amber Beserra
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

4.  The functional microscopic neuroanatomy of the human subthalamic nucleus.

Authors:  Anneke Alkemade; Gilles de Hollander; Steven Miletic; Max C Keuken; Rawien Balesar; Onno de Boer; Dick F Swaab; Birte U Forstmann
Journal:  Brain Struct Funct       Date:  2019-09-28       Impact factor: 3.270

5.  Immunopurification of pathological prion protein aggregates.

Authors:  Emiliano Biasini; Laura Tapella; Susanna Mantovani; Matteo Stravalaci; Marco Gobbi; David A Harris; Roberto Chiesa
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.